Spermosens AB (publ)
Research Spermosens AB (publ) (SPERM.ST) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerSPERM.ST
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencySEK
- Financial periodQ2 2026
- RevenueSEK 0
- Net income-SEK 2.78M
- Free cash flow-SEK 2.60M
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 0 | -SEK 9.20M | -SEK 8.84M | n/a | 0 | SEK 6.84M | SEK 0 | SEK 32.41M |
About Spermosens AB (publ)
Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What does Spermosens AB (publ) do?
Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.